Home  /  Resource Library  /  Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom Macroglobulinemia

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom Macroglobulinemia

Results of a study examining bortezomib combined with chemotheapy for first line treatment of Waldenstrom Macroglobulinemia. (Abstract only)